Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue
+10.5%
EPS
+6.00%
Free cash flow
−1.84%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

101.78 0.96 +0.95%
Market cap
$58.1B
P/E
56.7×
Fwd P/E
36.5×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a

Edwards Lifesciences Corporation (EW) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
United States 3,543 58.39%
Europe 1,518 25.01%
Rest of World 652 10.75%
Japan 355 5.85%
Gross margin 78.01%
Operating margin 20.84%
Pre-tax margin 20.98%

Revenue by product or service $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009 FY2008
Transcatheter Aortic Valve Replacement 4,488 4,106 3,880 3,518 3,423 2,857 2,738 2,284 2,024 1,629 1,180 944 708 552 334 206 — —
Surgical 1,029 981 933 830 889 762 842 762 807 775 785 826 801 788 784 732 — —
Transcatheter Mitral and Tricuspid Therapies 551 352 198 116 86 42 28 3 3 — — — — — — — — —
Critical Care — — — — 835 725 740 675 601 560 528 553 537 560 560 509 453 452
Heart Valve Therapy — — — — — — — — — — — — — — — — 715 607
Cardiac Surgery Systems — — — — — — — — — — — — — — — — 93 89
Vascular — — — — — — — — — — — — — — — — 61 89
Revenue 6,068 5,440 5,010 4,464 5,233 4,386 4,348 3,723 3,435 2,964 2,494 2,323 2,046 1,900 1,679 1,447 1,321 1,238

Gross profit by product or service $m, and margin

Revenue by segment $m

Line FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
United States 3,543 3,206 2,948 2,628 2,963 2,517 2,533 2,055 1,908 1,616 1,263 1,047 940 812 606
Europe 1,518 1,322 1,180 1,040 1,100 945 926 826 801 746 843 741 622 577 549
Rest of World 652 572 531 436 533 452 433 396 357 304 315 285 253 236 201
Japan 355 340 351 360 528 449 441 398 357 280 297 271 294 293 227
Other, not broken out — — — — 109 24 — 47 — 19 — — — — 96
Eliminations — — — — — — — — — — (224) (22) (63) (19) —
Revenue 6,068 5,440 5,010 4,464 5,233 4,386 4,348 3,723 3,435 2,964 2,494 2,323 2,046 1,900 1,679

Gross profit by segment $m, and margin

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.